Pablo Lemercier

664 total citations
15 papers, 308 citations indexed

About

Pablo Lemercier is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Pablo Lemercier has authored 15 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Pablo Lemercier's work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (6 papers) and Functional Brain Connectivity Studies (2 papers). Pablo Lemercier is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (6 papers) and Functional Brain Connectivity Studies (2 papers). Pablo Lemercier collaborates with scholars based in France, Italy and United Kingdom. Pablo Lemercier's co-authors include Harald Hampel, Simone Lista, Andrea Vergallo, Robert Nisticò, Filippo Baldacci, Enrica Cavedo, Francesco Garaci, Bruno Dubois, Alejandro Lucía and Kaj Blennow and has published in prestigious journals such as Annals of Surgery, Neurobiology of Aging and Neuropharmacology.

In The Last Decade

Pablo Lemercier

15 papers receiving 306 citations

Peers

Countries citing papers authored by Pablo Lemercier

Since Specialization

Citations

This map shows the geographic impact of Pablo Lemercier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Lemercier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Lemercier more than expected).

Fields of papers citing papers by Pablo Lemercier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Lemercier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Lemercier. The network helps show where Pablo Lemercier may publish in the future.

Co-authorship network of co-authors of Pablo Lemercier

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Lemercier. A scholar is included among the top collaborators of Pablo Lemercier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Lemercier. Pablo Lemercier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort 2024 ·ESMO Open ·(unknown), Xavier Quantin, Pablo Lemercier, C. Chouaïd, S. Schneider, Thomas Filleron, (unknown), M. Pérol, D. Debieuvre, Clarisse Audigier-Valette, (unknown), (unknown), Sandrine Hiret, Christelle Clément-Duchêne, Éric Dansin, (unknown), Éric Pichon, L. Bosquet, Nicolas Girard, Pauline du Rusquec	4
2	A Prospective European Trial Comparing Laparotomy, Laparoscopy, Robotic-assisted, and Transanal Total Mesorectal Excision Procedures in High-risk Patients With Rectal Cancer 2024 ·Annals of Surgery ·Philippe Rouanet, Mario Guerrieri, Pablo Lemercier, (unknown), Eddy Cotte, Antonino Spinelli, (unknown), Albert Wolthuis, Emilio Bertani, Anne Dubois, (unknown)	8
3	179O Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER-positive, HER2-negative breast cancer harboring homologous recombination repair (HRR) deficiency or microsatellite instability (MSI): Results of the international phase II DOLAF trial 2024 ·ESMO Open ·Séverine Guiu, Judith Balmañà, Pablo Lemercier, Philippe Follana, Amanda Gonçalves, Frédéric Bigot, Jean‐Sébastien Frenel, Étienne Brain, Audrey Mailliez, (unknown), Elsa Curtit, Olfa Derbel, (unknown), J-L. Canon, (unknown), (unknown), (unknown), Jérôme Lemonnier, (unknown), Suzette Delaloge	3
4	Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases 2022 ·Ageing Research Reviews ·Simone Lista, Andrea Vergallo, Stefan Teipel, Pablo Lemercier, Filippo Sean Giorgi, Audrey Gabelle, Francesco Garaci, Nicola Biagio Mercuri, Claudio Babiloni, Bhakta Prasad Gaire, Yosef Koronyo, Maya Koronyo‐Hamaoui, Harald Hampel, Robert Nisticò	26
5	Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease 2022 ·Alzheimer s & Dementia ·Herman Depypere, Andrea Vergallo, Pablo Lemercier, Simone Lista, Andréa Lessa Benedet, Nicholas J. Ashton, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen, Harald Hampel, (unknown)	31
6	Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease 2022 ·Journal of Personalized Medicine ·Pablo Lemercier, Laurent Cléret de Langavant, (unknown), Katia Youssov, (unknown), Étienne Audureau, Renaud Massart, Anne‐Catherine Bachoud‐Lévi	3
7	Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence 2021 ·Ageing Research Reviews ·Harald Hampel, Robert Nisticò, Nicholas T. Seyfried, Allan I. Levey, Erica Modeste, Pablo Lemercier, Filippo Baldacci, Nicola Toschi, Francesco Garaci, George Perry, Enzo Emanuele, Pedro L. Valenzuela, Alejandro Lucía, Andrea Urbani, Giulia Maria Sancesario, Mark Mapstone, Massimo Corbo, Andrea Vergallo, Simone Lista	97
8	Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease 2021 ·Neurobiology of Aging ·Pablo Lemercier, Andrea Vergallo, Simone Lista, Henrik Zetterberg, Kaj Blennow, Marie‐Claude Potier, Marie‐Odile Habert, François‐Xavier Lejeune, Bruno Dubois, Stefan Teipel, Harald Hampel	5
9	Plasma β‐secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD 2021 ·Alzheimer s & Dementia ·Andrea Vergallo, Pablo Lemercier, Enrica Cavedo, Simone Lista, Eugeen Vanmechelen, Ann De Vos, Henrik Zetterberg, Kaj Blennow, Marie‐Odile Habert, Marie‐Claude Potier, Bruno Dubois, Stefan Teipel, Harald Hampel, (unknown)	17
10	Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 andDownstream Pathway Model 2021 ·Current Neuropharmacology ·Harald Hampel, Simone Lista, Giuseppe Caruso, Robert Nisticò, (unknown), Nicola Biagio Mercuri, Filippo Sean Giorgi, Fabio Ferrarelli, Pablo Lemercier, Filippo Caraci, Andrea Vergallo, (unknown)	4
11	Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study 2020 ·Alzheimer s Research & Therapy ·(unknown), Filippo Baldacci, (unknown), Simone Lista, Maria Laura Manca, Patrizia A. Chiesa, Enrica Cavedo, Pablo Lemercier, Henrik Zetterberg, Kaj Blennow, Marie‐Odile Habert, Marie‐Claude Potier, Bruno Dubois, Andrea Vergallo, Harald Hampel	31
12	In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease 2020 ·Neurobiology of Aging ·Stefan Teipel, Martin Dyrba, Patrizia A. Chiesa, (unknown), (unknown), Simone Lista, Andrea Vergallo, Pablo Lemercier, Enrica Cavedo, (unknown), Bruno Dubois, Harald Hampel, Michel J. Grothe	21
13	Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 2020 ·Neuropharmacology ·Harald Hampel, Andrea Vergallo, Filippo Caraci, A. Claudio Cuello, Pablo Lemercier, Bruno Vellas, Kelly Virecoulon Giudici, Filippo Baldacci, (unknown), Marion Haberkamp, Karl Broich, Robert Nisticò, Enzo Emanuele, Francisco Llavero, José L. Zugaza, Alejandro Lucía, Ezio Giacobini, Simone Lista	34
14	Aging and sex impact plasma NFL and t‐Tau trajectories in individuals at risk for Alzheimer’s disease 2020 ·Alzheimer s & Dementia ·Filippo Baldacci, Simone Lista, Maria Laura Manca, Pablo Lemercier, Patrizia A. Chiesa, Henrik Zetterberg, Kaj Blennow, Marie‐Claude Potier, Marie‐Odile Habert, Enrica Cavedo, Bruno Dubois, Andrea Vergallo, Harald Hampel	1
15	Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 2019 ·Alzheimer s & Dementia ·Andrea Vergallo, Marion Houot, Enrica Cavedo, Pablo Lemercier, Eugeen Vanmechelen, Ann De Vos, Marie‐Odile Habert, Marie‐Claude Potier, Bruno Dubois, Simone Lista, Harald Hampel, (unknown), (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact